Opioid-Free Pain Treatment in Trauma Patients
Peri-operative Opioid-free Analgesic Protocol for Orthopedic Trauma Patients
1 other identifier
interventional
250
1 country
1
Brief Summary
Analgesic drug study that will compare pain outcomes of opioid analgesia and opioid-free analgesia in post-operative orthopedic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2023
CompletedFirst Posted
Study publicly available on registry
October 11, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
October 26, 2024
October 1, 2024
2.9 years
October 5, 2023
October 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numerical Rating Scale (NRS) Pain Scores
Patients will be asked how much pain they are experiencing on a 1-10 scale after their surgery. Lower scores mean better outcomes and less pain, higher scores mean worse outcomes.
From post surgery up until 6 months post surgery
Secondary Outcomes (3)
Postoperative complications
From post surgery up until 6 months post surgery
Medication usage (timing)
From post surgery up until 6 months post surgery
Medication usage (quantity)
From post surgery up until 6 months post surgery
Study Arms (2)
Opioid pain treatment (Block 1)
NO INTERVENTIONStandard of care pain treatment regimen that involves the use of opioids. Discretion of the medical care team and surgeon will be used for specific opioid pain treatment prescription (quantity, frequency) based on standard of care procedures. All forms of treatment are allowed for the standard of care group which may include but are not limited to blocks, opioids, patient-controlled analgesia, NSAIDs, acetaminophen, muscle relaxing agents, sedation medications, and neuropathic pain medications.
Opioid-Free pain treatment (Block 2)
EXPERIMENTALPain treatment regiment without the use of opioids. All other pain medication may be used under the discretion of the medical care team and surgeon.
Interventions
Pain treatment includes any medications up to the medical team's discretion aside from opioids.
Eligibility Criteria
You may qualify if:
- Patient is over the age of 18 years old
- Underwent surgical treatment for the injuries of interest (stated elsewhere) by an Orthopedic Traumatology Attending Physician at the University of Kansas Hospital
You may not qualify if:
- Patients that are unable to provide informed consent due to sustaining a head injury or incoherence from narcotics given to them post-injury
- Chronic opioid use
- Under the age of 18 years old
- Undergoing revision surgery
- Did not undergo surgical fixation
- Pregnant/nursing women
- Vulnerable populations as defined by the University of Kansas Medical Center IRB
- Did not experience one of the following fractures listed in D.1. above.
- Patients with CKD and/or cirrhosis will be excluded from the opioid-free pain block (block 2) and will only qualify for the standard of care opioid group (Block 1)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Kansas Medical Center
Kansas City, Kansas, 66103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 5, 2023
First Posted
October 11, 2023
Study Start
November 1, 2023
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
October 26, 2024
Record last verified: 2024-10